{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:02:41Z","timestamp":1793642561471,"version":"4.5.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901303"],"award-info":[{"award-number":["81901303"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s12035-025-04726-7","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T19:32:27Z","timestamp":1738697547000},"page":"6612-6625","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Short-Chain Fatty Acid Aggregates Alpha-Synuclein Accumulation and Neuroinflammation via GPR43-NLRP3 Signaling Pathway in a Model Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"62","author":[{"given":"Yi","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danlei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijuan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"issue":"9996","key":"4726_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/s0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet (London, England) 386(9996):896\u2013912. https:\/\/doi.org\/10.1016\/s0140-6736(14)61393-3","journal-title":"Lancet (London, England)"},{"issue":"5","key":"4726_CR2","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1007\/s00415-012-6801-2","volume":"260","author":"MG Cersosimo","year":"2013","unstructured":"Cersosimo MG, Raina GB, Pecci C, Pellene A, Calandra CR, Guti\u00e9rrez C, Micheli FE, Benarroch EE (2013) Gastrointestinal manifestations in Parkinson\u2019s disease: prevalence and occurrence before motor symptoms. J Neurol 260(5):1332\u20131338. https:\/\/doi.org\/10.1007\/s00415-012-6801-2","journal-title":"J Neurol"},{"issue":"6","key":"4726_CR3","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","volume":"33","author":"CH Hawkes","year":"2007","unstructured":"Hawkes CH, Del Tredici K, Braak H (2007) Parkinson\u2019s disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol 33(6):599\u2013614. https:\/\/doi.org\/10.1111\/j.1365-2990.2007.00874.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"4726_CR4","doi-asserted-by":"publisher","first-page":"937555","DOI":"10.3389\/fimmu.2022.937555","volume":"13","author":"M Zhu","year":"2022","unstructured":"Zhu M, Liu X, Ye Y, Yan X, Cheng Y, Zhao L, Chen F, Ling Z (2022) Gut microbiota: a novel therapeutic target for Parkinson\u2019s disease. Front Immunol 13:937555. https:\/\/doi.org\/10.3389\/fimmu.2022.937555","journal-title":"Front Immunol"},{"issue":"10","key":"4726_CR5","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.4103\/1673-5374.391304","volume":"19","author":"PM Neufeld","year":"2024","unstructured":"Neufeld PM, Nettersheim RA, Matschke V, Vorgerd M, Stahlke S, Theiss C (2024) Unraveling the gut-brain axis: the impact of steroid hormones and nutrition on Parkinson\u2019s disease. Neural Regen Res 19(10):2219\u20132228. https:\/\/doi.org\/10.4103\/1673-5374.391304","journal-title":"Neural Regen Res"},{"issue":"1","key":"4726_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13024-020-00368-6","volume":"15","author":"BA Hijaz","year":"2020","unstructured":"Hijaz BA, Volpicelli-Daley LA (2020) Initiation and propagation of \u03b1-synuclein aggregation in the nervous system. Mol Neurodegener 15(1):19. https:\/\/doi.org\/10.1186\/s13024-020-00368-6","journal-title":"Mol Neurodegener"},{"key":"4726_CR7","doi-asserted-by":"publisher","unstructured":"Lei Q, Wu T, Wu J, Hu X, Guan Y, Wang Y, Yan J, Shi G (2021) Roles of \u03b1\u2011synuclein in gastrointestinal microbiome dysbiosis\u2011related Parkinson's disease progression (Review). Molecular medicine reports 24 (4). https:\/\/doi.org\/10.3892\/mmr.2021.12374","DOI":"10.3892\/mmr.2021.12374"},{"key":"4726_CR8","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fnins.2019.00369","volume":"13","author":"E Fitzgerald","year":"2019","unstructured":"Fitzgerald E, Murphy S, Martinson HA (2019) Alpha-synuclein pathology and the role of the microbiota in Parkinson\u2019s disease. Front Neurosci 13:369. https:\/\/doi.org\/10.3389\/fnins.2019.00369","journal-title":"Front Neurosci"},{"key":"4726_CR9","doi-asserted-by":"publisher","unstructured":"Pajares M, A IR, Manda G, Bosc\u00e1 L, Cuadrado A (2020) Inflammation in Parkinson's disease: mechanisms and therapeutic implications. Cells 9 (7). https:\/\/doi.org\/10.3390\/cells9071687","DOI":"10.3390\/cells9071687"},{"issue":"7","key":"4726_CR10","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s10571-021-01093-4","volume":"42","author":"I Khan","year":"2022","unstructured":"Khan I, Preeti K, Fernandes V, Khatri DK, Singh SB (2022) Role of MicroRNAs, aptamers in neuroinflammation and neurodegenerative disorders. Cell Mol Neurobiol 42(7):2075\u20132095. https:\/\/doi.org\/10.1007\/s10571-021-01093-4","journal-title":"Cell Mol Neurobiol"},{"key":"4726_CR11","doi-asserted-by":"publisher","first-page":"175300","DOI":"10.1016\/j.ejphar.2022.175300","volume":"934","author":"M Khot","year":"2022","unstructured":"Khot M, Sood A, Tryphena KP, Khan S, Srivastava S, Singh SB, Khatri DK (2022) NLRP3 inflammasomes: a potential target to improve mitochondrial biogenesis in Parkinson\u2019s disease. Eur J Pharmacol 934:175300. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175300","journal-title":"Eur J Pharmacol"},{"key":"4726_CR12","doi-asserted-by":"publisher","first-page":"115496","DOI":"10.1016\/j.bcp.2023.115496","volume":"210","author":"S Samim Khan","year":"2023","unstructured":"Samim Khan S, Janrao S, Srivastava S, Bala Singh S, Vora L, Kumar Khatri D (2023) GSK-3\u03b2: An exuberating neuroinflammatory mediator in Parkinson\u2019s disease. Biochem Pharmacol 210:115496. https:\/\/doi.org\/10.1016\/j.bcp.2023.115496","journal-title":"Biochem Pharmacol"},{"key":"4726_CR13","doi-asserted-by":"publisher","unstructured":"Gordon R, Albornoz EA, Christie DC, Langley MR, Kumar V, Mantovani S, Robertson AAB, Butler MS, Rowe DB, O'Neill LA, Kanthasamy AG, Schroder K, Cooper MA, Woodruff TM (2018) Inflammasome inhibition prevents \u03b1-synuclein pathology and dopaminergic neurodegeneration in mice. Science translational medicine 10 (465). https:\/\/doi.org\/10.1126\/scitranslmed.aah4066","DOI":"10.1126\/scitranslmed.aah4066"},{"issue":"15","key":"4726_CR14","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.neuron.2022.05.009","volume":"110","author":"N Panicker","year":"2022","unstructured":"Panicker N, Kam TI, Wang H, Neifert S, Chou SC, Kumar M, Brahmachari S, Jhaldiyal A, Hinkle JT, Akkentli F, Mao X, Xu E, Karuppagounder SS, Hsu ET, Kang SU, Pletnikova O, Troncoso J, Dawson VL, Dawson TM (2022) Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson\u2019s disease. Neuron 110(15):2422-2437.e2429. https:\/\/doi.org\/10.1016\/j.neuron.2022.05.009","journal-title":"Neuron"},{"issue":"8335","key":"4726_CR15","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/s0140-6736(83)92478-9","volume":"1","author":"JH Cummings","year":"1983","unstructured":"Cummings JH (1983) Fermentation in the human large intestine: evidence and implications for health. Lancet (London, England) 1(8335):1206\u20131209. https:\/\/doi.org\/10.1016\/s0140-6736(83)92478-9","journal-title":"Lancet (London, England)"},{"issue":"1","key":"4726_CR16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12967-021-02995-z","volume":"19","author":"X Lin","year":"2021","unstructured":"Lin X, Liu Y, Ma L, Ma X, Shen L, Ma X, Chen Z, Chen H, Li D, Su Z, Chen X (2021) Constipation induced gut microbiota dysbiosis exacerbates experimental autoimmune encephalomyelitis in C57BL\/6 mice. J Transl Med 19(1):317. https:\/\/doi.org\/10.1186\/s12967-021-02995-z","journal-title":"J Transl Med"},{"issue":"4","key":"4726_CR17","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, Lee JH, Kim WR, Kook M, Foss CA, Shen C, Lee H, Kulkarni S, Pasricha PJ, Lee G, Pomper MG, Dawson VL, Dawson TM, Ko HS (2019) Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron 103(4):627-641.e627. https:\/\/doi.org\/10.1016\/j.neuron.2019.05.035","journal-title":"Neuron"},{"issue":"8","key":"4726_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","volume":"16","author":"B Dalile","year":"2019","unstructured":"Dalile B, Van Oudenhove L, Vervliet B, Verbeke K (2019) The role of short-chain fatty acids in microbiota-gut-brain communication. Nat Rev Gastroenterol Hepatol 16(8):461\u2013478. https:\/\/doi.org\/10.1038\/s41575-019-0157-3","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4726_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jns.2017.08.3235","volume":"381","author":"J Liu","year":"2017","unstructured":"Liu J, Wang F, Liu S, Du J, Hu X, Xiong J, Fang R, Chen W, Sun J (2017) Sodium butyrate exerts protective effect against Parkinson\u2019s disease in mice via stimulation of glucagon like peptide-1. J Neurol Sci 381:176\u2013181. https:\/\/doi.org\/10.1016\/j.jns.2017.08.3235","journal-title":"J Neurol Sci"},{"issue":"6","key":"4726_CR20","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1021\/acschemneuro.2c00803","volume":"14","author":"A Majumdar","year":"2023","unstructured":"Majumdar A, Siva Venkatesh IP, Basu A (2023) Short-chain fatty acids in the microbiota-gut-brain axis: role in neurodegenerative disorders and viral infections. ACS Chem Neurosci 14(6):1045\u20131062. https:\/\/doi.org\/10.1021\/acschemneuro.2c00803","journal-title":"ACS Chem Neurosci"},{"key":"4726_CR21","doi-asserted-by":"publisher","unstructured":"Zhou ZL, Jia XB, Sun MF, Zhu YL, Qiao CM, Zhang BP, Zhao LP, Yang Q, Cui C, Chen X, Shen YQ (2019) Neuroprotection of fasting mimicking diet on MPTP-induced parkinson's disease mice via gut microbiota and metabolites. neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 16(3):741\u2013760. https:\/\/doi.org\/10.1007\/s13311-019-00719-2","DOI":"10.1007\/s13311-019-00719-2"},{"key":"4726_CR22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbi.2018.02.005","volume":"70","author":"MF Sun","year":"2018","unstructured":"Sun MF, Zhu YL, Zhou ZL, Jia XB, Xu YD, Yang Q, Cui C, Shen YQ (2018) Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson\u2019s disease mice: gut microbiota, glial reaction and TLR4\/TNF-\u03b1 signaling pathway. Brain Behav Immun 70:48\u201360. https:\/\/doi.org\/10.1016\/j.bbi.2018.02.005","journal-title":"Brain Behav Immun"},{"issue":"6","key":"4726_CR23","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, Challis C, Schretter CE, Rocha S, Gradinaru V, Chesselet MF, Keshavarzian A, Shannon KM, Krajmalnik-Brown R, Wittung-Stafshede P, Knight R, Mazmanian SK (2016) Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell 167(6):1469-1480.e1412. https:\/\/doi.org\/10.1016\/j.cell.2016.11.018","journal-title":"Cell"},{"key":"4726_CR24","doi-asserted-by":"publisher","unstructured":"Seo DO, O'Donnell D, Jain N, Ulrich JD, Herz J, Li Y, Lemieux M, Cheng J, Hu H, Serrano JR, Bao X, Franke E, Karlsson M, Meier M, Deng S, Desai C, Dodiya H, Lelwala-Guruge J, Handley SA, Kipnis J, Sisodia SS, Gordon JI, Holtzman DM (2023) ApoE isoform- and microbiota-dependent progression of neurodegeneration in a mouse model of tauopathy. Science (New York, NY) 379 (6628):eadd1236. https:\/\/doi.org\/10.1126\/science.add1236","DOI":"10.1126\/science.add1236"},{"key":"4726_CR25","doi-asserted-by":"publisher","unstructured":"Xu J, Moore BN, Pluznick JL (2022) Short-chain fatty acid receptors and blood pressure regulation: Council on Hypertension Mid-Career Award for Research Excellence 2021. Hypertension (Dallas, Tex : 1979) 79 (10):2127\u20132137. https:\/\/doi.org\/10.1161\/hypertensionaha.122.18558","DOI":"10.1161\/hypertensionaha.122.18558"},{"key":"4726_CR26","doi-asserted-by":"publisher","unstructured":"Kim MH, Kang SG, Park JH, Yanagisawa M, Kim CH (2013) Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology 145 (2):396\u2013406.e391\u2013310. https:\/\/doi.org\/10.1053\/j.gastro.2013.04.056","DOI":"10.1053\/j.gastro.2013.04.056"},{"key":"4726_CR27","doi-asserted-by":"publisher","first-page":"38231","DOI":"10.1038\/srep38231","volume":"6","author":"WH Aisenberg","year":"2016","unstructured":"Aisenberg WH, Huang J, Zhu W, Rajkumar P, Cruz R, Santhanam L, Natarajan N, Yong HM, De Santiago B, Oh JJ, Yoon AR, Panettieri RA, Homann O, Sullivan JK, Liggett SB, Pluznick JL, An SS (2016) Defining an olfactory receptor function in airway smooth muscle cells. Sci Rep 6:38231. https:\/\/doi.org\/10.1038\/srep38231","journal-title":"Sci Rep"},{"issue":"10","key":"4726_CR28","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.7150\/ijbs.70644","volume":"18","author":"K Zuo","year":"2022","unstructured":"Zuo K, Fang C, Liu Z, Fu Y, Liu Y, Liu L, Wang Y, Yin X, Liu X, Li J, Zhong J, Chen M, Xu L, Yang X (2022) Commensal microbe-derived SCFA alleviates atrial fibrillation via GPR43\/NLRP3 signaling. Int J Biol Sci 18(10):4219\u20134232. https:\/\/doi.org\/10.7150\/ijbs.70644","journal-title":"Int J Biol Sci"},{"issue":"3","key":"4726_CR29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1530\/jme-15-0293","volume":"56","author":"RE Kuhre","year":"2016","unstructured":"Kuhre RE, Wewer Albrechtsen NJ, Deacon CF, Balk-M\u00f8ller E, Rehfeld JF, Reimann F, Gribble FM, Holst JJ (2016) Peptide production and secretion in GLUTag, NCI-H716, and STC-1 cells: a comparison to native L-cells. J Mol Endocrinol 56(3):201\u2013211. https:\/\/doi.org\/10.1530\/jme-15-0293","journal-title":"J Mol Endocrinol"},{"key":"4726_CR30","doi-asserted-by":"publisher","unstructured":"(2015). In: Verhoeckx K, Cotter P, L\u00f3pez-Exp\u00f3sito I et al. (eds) The impact of food bioactives on health: in vitro and ex vivo models. Springer Copyright 2015, The Editor(s) (if applicable) and the Author(s). Cham (CH). https:\/\/doi.org\/10.1007\/978-3-319-16104-4","DOI":"10.1007\/978-3-319-16104-4"},{"issue":"12","key":"4726_CR31","doi-asserted-by":"publisher","first-page":"10839","DOI":"10.1039\/d0fo01536a","volume":"11","author":"ZJ Ma","year":"2020","unstructured":"Ma ZJ, Wang HJ, Ma XJ, Li Y, Yang HJ, Li H, Su JR, Zhang CE, Huang LQ (2020) Modulation of gut microbiota and intestinal barrier function during alleviation of antibiotic-associated diarrhea with Rhizoma Zingiber officinale (Ginger) extract. Food Funct 11(12):10839\u201310851. https:\/\/doi.org\/10.1039\/d0fo01536a","journal-title":"Food Funct"},{"issue":"7","key":"4726_CR32","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nn.4030","volume":"18","author":"D Erny","year":"2015","unstructured":"Erny D, Hrab\u011b de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E, Keren-Shaul H, Mahlakoiv T, Jakobshagen K, Buch T, Schwierzeck V, Uterm\u00f6hlen O, Chun E, Garrett WS, McCoy KD, Diefenbach A, Staeheli P, Stecher B, Amit I, Prinz M (2015) Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci 18(7):965\u2013977. https:\/\/doi.org\/10.1038\/nn.4030","journal-title":"Nat Neurosci"},{"issue":"4","key":"4726_CR33","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1007\/s11064-017-2185-0","volume":"42","author":"Z Mao","year":"2017","unstructured":"Mao Z, Liu C, Ji S, Yang Q, Ye H, Han H, Xue Z (2017) The NLRP3 inflammasome is involved in the pathogenesis of Parkinson\u2019s disease in rats. Neurochem Res 42(4):1104\u20131115. https:\/\/doi.org\/10.1007\/s11064-017-2185-0","journal-title":"Neurochem Res"},{"key":"4726_CR34","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.pharmthera.2016.04.007","volume":"164","author":"S Sivaprakasam","year":"2016","unstructured":"Sivaprakasam S, Prasad PD, Singh N (2016) Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis. Pharmacol Ther 164:144\u2013151. https:\/\/doi.org\/10.1016\/j.pharmthera.2016.04.007","journal-title":"Pharmacol Ther"},{"issue":"6","key":"4726_CR35","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/ana.24648","volume":"79","author":"MG Stokholm","year":"2016","unstructured":"Stokholm MG, Danielsen EH, Hamilton-Dutoit SJ, Borghammer P (2016) Pathological \u03b1-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients. Ann Neurol 79(6):940\u2013949. https:\/\/doi.org\/10.1002\/ana.24648","journal-title":"Ann Neurol"},{"issue":"1","key":"4726_CR36","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/mds.26866","volume":"32","author":"K Knudsen","year":"2017","unstructured":"Knudsen K, Krogh K, \u00d8stergaard K, Borghammer P (2017) Constipation in Parkinson\u2019s disease: Subjective symptoms, objective markers, and new perspectives. Movement Disorders\u202f: Official J Movement Disorder Soc 32(1):94\u2013105. https:\/\/doi.org\/10.1002\/mds.26866","journal-title":"Movement Disorders : Official J Movement Disorder Soc"},{"issue":"3","key":"4726_CR37","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","volume":"7","author":"DJ Morrison","year":"2016","unstructured":"Morrison DJ, Preston T (2016) Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut microbes 7(3):189\u2013200. https:\/\/doi.org\/10.1080\/19490976.2015.1134082","journal-title":"Gut microbes"},{"issue":"5","key":"4726_CR38","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1053\/j.gastro.2010.01.053","volume":"138","author":"R Soret","year":"2010","unstructured":"Soret R, Chevalier J, De Coppet P, Poupeau G, Derkinderen P, Segain JP, Neunlist M (2010) Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats. Gastroenterology 138(5):1772\u20131782. https:\/\/doi.org\/10.1053\/j.gastro.2010.01.053","journal-title":"Gastroenterology"},{"key":"4726_CR39","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","volume":"32","author":"MM Unger","year":"2016","unstructured":"Unger MM, Spiegel J, Dillmann KU, Grundmann D, Philippeit H, B\u00fcrmann J, Fa\u00dfbender K, Schwiertz A, Sch\u00e4fer KH (2016) Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls. Parkinsonism Relat Disord 32:66\u201372. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.08.019","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"4726_CR40","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/mds.28016","volume":"35","author":"C Shin","year":"2020","unstructured":"Shin C, Lim Y, Lim H, Ahn TB (2020) Plasma short-chain fatty acids in patients with Parkinson\u2019s disease. Movement Disorders\u202f: Official J Movement Disorder Soc 35(6):1021\u20131027. https:\/\/doi.org\/10.1002\/mds.28016","journal-title":"Movement Disorders : Official J Movement Disorder Soc"},{"key":"4726_CR41","doi-asserted-by":"publisher","unstructured":"Mirzaei R, Bouzari B, Hosseini-Fard SR, Mazaheri M, Ahmadyousefi Y, Abdi M, Jalalifar S, Karimitabar Z, Teimoori A, Keyvani H, Zamani F, Yousefimashouf R, Karampoor S (2021) Role of microbiota-derived short-chain fatty acids in nervous system disorders. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 139:111661. https:\/\/doi.org\/10.1016\/j.biopha.2021.111661","DOI":"10.1016\/j.biopha.2021.111661"},{"issue":"4","key":"4726_CR42","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s12264-023-01123-9","volume":"40","author":"WX Duan","year":"2024","unstructured":"Duan WX, Wang F, Liu JY, Liu CF (2024) Relationship between short-chain fatty acids and Parkinson\u2019s disease: a review from pathology to clinic. Neurosci Bull 40(4):500\u2013516. https:\/\/doi.org\/10.1007\/s12264-023-01123-9","journal-title":"Neurosci Bull"},{"key":"4726_CR43","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","volume":"10","author":"D Parada Venegas","year":"2019","unstructured":"Parada Venegas D, De la Fuente MK, Landskron G, Gonz\u00e1lez MJ, Quera R, Dijkstra G, Harmsen HJM, Faber KN, Hermoso MA (2019) Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol 10:277. https:\/\/doi.org\/10.3389\/fimmu.2019.00277","journal-title":"Front Immunol"},{"key":"4726_CR44","doi-asserted-by":"publisher","unstructured":"Guo TT, Zhang Z, Sun Y, Zhu RY, Wang FX, Ma LJ, Jiang L, Liu HD (2023) Neuroprotective effects of sodium butyrate by restoring gut microbiota and inhibiting TLR4 signaling in mice with MPTP-induced Parkinson's disease. Nutrients 15 (4). https:\/\/doi.org\/10.3390\/nu15040930","DOI":"10.3390\/nu15040930"},{"issue":"1","key":"4726_CR45","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.immuni.2013.12.007","volume":"40","author":"N Singh","year":"2014","unstructured":"Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H, Thangaraju M, Prasad PD, Manicassamy S, Munn DH, Lee JR, Offermanns S, Ganapathy V (2014) Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40(1):128\u2013139. https:\/\/doi.org\/10.1016\/j.immuni.2013.12.007","journal-title":"Immunity"},{"issue":"9","key":"4726_CR46","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1007\/s11064-020-03074-3","volume":"45","author":"CM Qiao","year":"2020","unstructured":"Qiao CM, Sun MF, Jia XB, Li Y, Zhang BP, Zhao LP, Shi Y, Zhou ZL, Zhu YL, Cui C, Shen YQ (2020) Sodium butyrate exacerbates Parkinson\u2019s disease by aggravating neuroinflammation and colonic inflammation in MPTP-induced mice model. Neurochem Res 45(9):2128\u20132142. https:\/\/doi.org\/10.1007\/s11064-020-03074-3","journal-title":"Neurochem Res"},{"issue":"7","key":"4726_CR47","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1210\/en.2018-00261","volume":"159","author":"VB Lu","year":"2018","unstructured":"Lu VB, Gribble FM, Reimann F (2018) Free fatty acid receptors in enteroendocrine cells. Endocrinology 159(7):2826\u20132835. https:\/\/doi.org\/10.1210\/en.2018-00261","journal-title":"Endocrinology"},{"key":"4726_CR48","doi-asserted-by":"publisher","unstructured":"Schiweck C, Edwin Thanarajah S, Aichholzer M, Matura S, Reif A, Vrieze E, Weigert A, Visekruna A (2022) Regulation of CD4(+) and CD8(+) T cell biology by short-chain fatty acids and its relevance for autoimmune pathology. International journal of molecular sciences 23 (15). https:\/\/doi.org\/10.3390\/ijms23158272","DOI":"10.3390\/ijms23158272"},{"key":"4726_CR49","doi-asserted-by":"publisher","unstructured":"Sam QH, Ling H, Yew WS, Tan Z, Ravikumar S, Chang MW, Chai LYA (2021) The divergent immunomodulatory effects of short chain fatty acids and medium chain fatty acids. International journal of molecular sciences 22 (12). https:\/\/doi.org\/10.3390\/ijms22126453","DOI":"10.3390\/ijms22126453"},{"issue":"1","key":"4726_CR50","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1038\/s41467-020-16079-x","volume":"11","author":"C Coutzac","year":"2020","unstructured":"Coutzac C, Jouniaux JM, Paci A, Schmidt J, Mallardo D, Seck A, Asvatourian V, Cassard L, Saulnier P, Lacroix L, Woerther PL, Vozy A, Naigeon M, Nebot-Bral L, Desbois M, Simeone E, Mateus C, Boselli L, Grivel J, Soularue E, Lepage P, Carbonnel F, Ascierto PA, Robert C, Chaput N (2020) Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer. Nat Commun 11(1):2168. https:\/\/doi.org\/10.1038\/s41467-020-16079-x","journal-title":"Nat Commun"},{"issue":"8","key":"4726_CR51","doi-asserted-by":"publisher","first-page":"e848","DOI":"10.1212\/wnl.0000000000013225","volume":"98","author":"SJ Chen","year":"2022","unstructured":"Chen SJ, Chen CC, Liao HY, Lin YT, Wu YW, Liou JM, Wu MS, Kuo CH, Lin CH (2022) Association of fecal and plasma levels of short-chain fatty acids with gut microbiota and clinical severity in patients with Parkinson disease. Neurology 98(8):e848\u2013e858. https:\/\/doi.org\/10.1212\/wnl.0000000000013225","journal-title":"Neurology"},{"issue":"5","key":"4726_CR52","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1084\/jem.20150237","volume":"214","author":"L Freeman","year":"2017","unstructured":"Freeman L, Guo H, David CN, Brickey WJ, Jha S, Ting JP (2017) NLR members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes. J Exp Med 214(5):1351\u20131370. https:\/\/doi.org\/10.1084\/jem.20150237","journal-title":"J Exp Med"},{"issue":"8","key":"4726_CR53","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","volume":"17","author":"MSJ Mangan","year":"2018","unstructured":"Mangan MSJ, Olhava EJ, Roush WR, Seidel HM, Glick GD, Latz E (2018) Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discovery 17(8):588\u2013606. https:\/\/doi.org\/10.1038\/nrd.2018.97","journal-title":"Nat Rev Drug Discovery"},{"issue":"1","key":"4726_CR54","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.1038\/s41467-018-06048-w","volume":"9","author":"H Fujiwara","year":"2018","unstructured":"Fujiwara H, Docampo MD, Riwes M, Peltier D, Toubai T, Henig I, Wu SJ, Kim S, Taylor A, Brabbs S, Liu C, Zajac C, Oravecz-Wilson K, Sun Y, N\u00fa\u00f1ez G, Levine JE, van den Brink MRM, Ferrara JLM, Reddy P (2018) Microbial metabolite sensor GPR43 controls severity of experimental GVHD. Nat Commun 9(1):3674. https:\/\/doi.org\/10.1038\/s41467-018-06048-w","journal-title":"Nat Commun"},{"issue":"6","key":"4726_CR55","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.cell.2020.04.049","volume":"181","author":"A Vaccaro","year":"2020","unstructured":"Vaccaro A, Kaplan Dor Y, Nambara K, Pollina EA, Lin C, Greenberg ME, Rogulja D (2020) Sleep Loss can cause death through accumulation of reactive oxygen species in the gut. Cell 181(6):1307-1328.e1315. https:\/\/doi.org\/10.1016\/j.cell.2020.04.049","journal-title":"Cell"},{"key":"4726_CR56","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3389\/fneur.2019.00663","volume":"10","author":"TM Cantu-Jungles","year":"2019","unstructured":"Cantu-Jungles TM, Rasmussen HE, Hamaker BR (2019) Potential of prebiotic butyrogenic fibers in Parkinson\u2019s disease. Front Neurol 10:663. https:\/\/doi.org\/10.3389\/fneur.2019.00663","journal-title":"Front Neurol"},{"key":"4726_CR57","doi-asserted-by":"publisher","unstructured":"Abdel-Haq R, Schlachetzki JCM, Boktor JC, Cantu-Jungles TM, Thron T, Zhang M, Bostick JW, Khazaei T, Chilakala S, Morais LH, Humphrey G, Keshavarzian A, Katz JE, Thomson M, Knight R, Gradinaru V, Hamaker BR, Glass CK, Mazmanian SK (2022) A prebiotic diet modulates microglial states and motor deficits in \u03b1-synuclein overexpressing mice. eLife 11. https:\/\/doi.org\/10.7554\/eLife.81453","DOI":"10.7554\/eLife.81453"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04726-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-04726-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04726-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:10:18Z","timestamp":1743379818000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-04726-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["4726"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-04726-7","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,4]]},"assertion":[{"value":"12 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}}]}}